nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Tamoxifen—pancreatic cancer	0.0106	0.24	CbGbCtD
Sibutramine—CYP3A4—Erlotinib—pancreatic cancer	0.00905	0.204	CbGbCtD
Sibutramine—CYP3A4—Irinotecan—pancreatic cancer	0.00817	0.185	CbGbCtD
Sibutramine—CYP3A4—Docetaxel—pancreatic cancer	0.00599	0.135	CbGbCtD
Sibutramine—CYP3A4—Sunitinib—pancreatic cancer	0.00596	0.135	CbGbCtD
Sibutramine—CYP3A4—Doxorubicin—pancreatic cancer	0.00446	0.101	CbGbCtD
Sibutramine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000385	0.000403	CcSEcCtD
Sibutramine—Cough—Docetaxel—pancreatic cancer	0.000385	0.000403	CcSEcCtD
Sibutramine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000385	0.000403	CcSEcCtD
Sibutramine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000384	0.000401	CcSEcCtD
Sibutramine—Pneumonia—Epirubicin—pancreatic cancer	0.000383	0.000401	CcSEcCtD
Sibutramine—Convulsion—Docetaxel—pancreatic cancer	0.000382	0.0004	CcSEcCtD
Sibutramine—Hypertension—Docetaxel—pancreatic cancer	0.000381	0.000398	CcSEcCtD
Sibutramine—Bronchitis—Doxorubicin—pancreatic cancer	0.00038	0.000398	CcSEcCtD
Sibutramine—Arthralgia—Docetaxel—pancreatic cancer	0.000376	0.000393	CcSEcCtD
Sibutramine—Chest pain—Docetaxel—pancreatic cancer	0.000376	0.000393	CcSEcCtD
Sibutramine—Myalgia—Docetaxel—pancreatic cancer	0.000376	0.000393	CcSEcCtD
Sibutramine—Nausea—Sunitinib—pancreatic cancer	0.000376	0.000393	CcSEcCtD
Sibutramine—Renal failure—Epirubicin—pancreatic cancer	0.000374	0.000392	CcSEcCtD
Sibutramine—Asthenia—Irinotecan—pancreatic cancer	0.000374	0.000391	CcSEcCtD
Sibutramine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000373	0.00039	CcSEcCtD
Sibutramine—Stomatitis—Epirubicin—pancreatic cancer	0.000371	0.000388	CcSEcCtD
Sibutramine—Urinary tract infection—Epirubicin—pancreatic cancer	0.00037	0.000387	CcSEcCtD
Sibutramine—Conjunctivitis—Epirubicin—pancreatic cancer	0.00037	0.000387	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—pancreatic cancer	0.000369	0.000387	CcSEcCtD
Sibutramine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000367	0.000384	CcSEcCtD
Sibutramine—Dry mouth—Docetaxel—pancreatic cancer	0.000367	0.000384	CcSEcCtD
Sibutramine—Sweating—Epirubicin—pancreatic cancer	0.000365	0.000382	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000365	0.000382	CcSEcCtD
Sibutramine—Asthenia—Gemcitabine—pancreatic cancer	0.000364	0.000381	CcSEcCtD
Sibutramine—Haematuria—Epirubicin—pancreatic cancer	0.000363	0.00038	CcSEcCtD
Sibutramine—Confusional state—Docetaxel—pancreatic cancer	0.000363	0.00038	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000361	0.000377	CcSEcCtD
Sibutramine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00036	0.000377	CcSEcCtD
Sibutramine—Oedema—Docetaxel—pancreatic cancer	0.00036	0.000377	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—pancreatic cancer	0.00036	0.000376	CcSEcCtD
Sibutramine—Epistaxis—Epirubicin—pancreatic cancer	0.000359	0.000376	CcSEcCtD
Sibutramine—Pruritus—Gemcitabine—pancreatic cancer	0.000359	0.000376	CcSEcCtD
Sibutramine—Infection—Docetaxel—pancreatic cancer	0.000358	0.000374	CcSEcCtD
Sibutramine—Sinusitis—Epirubicin—pancreatic cancer	0.000357	0.000374	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000356	0.000373	CcSEcCtD
Sibutramine—Diarrhoea—Irinotecan—pancreatic cancer	0.000356	0.000373	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—pancreatic cancer	0.000354	0.000371	CcSEcCtD
Sibutramine—Shock—Docetaxel—pancreatic cancer	0.000354	0.000371	CcSEcCtD
Sibutramine—Pruritus—Fluorouracil—pancreatic cancer	0.000353	0.000369	CcSEcCtD
Sibutramine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000352	0.000369	CcSEcCtD
Sibutramine—Tachycardia—Docetaxel—pancreatic cancer	0.000351	0.000368	CcSEcCtD
Sibutramine—Skin disorder—Docetaxel—pancreatic cancer	0.00035	0.000366	CcSEcCtD
Sibutramine—Bradycardia—Epirubicin—pancreatic cancer	0.000348	0.000364	CcSEcCtD
Sibutramine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000347	0.000363	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—pancreatic cancer	0.000346	0.000362	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000345	0.000361	CcSEcCtD
Sibutramine—Dizziness—Irinotecan—pancreatic cancer	0.000344	0.00036	CcSEcCtD
Sibutramine—Haemoglobin—Epirubicin—pancreatic cancer	0.000344	0.000359	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—pancreatic cancer	0.000343	0.000359	CcSEcCtD
Sibutramine—Anorexia—Docetaxel—pancreatic cancer	0.000343	0.000359	CcSEcCtD
Sibutramine—Rhinitis—Epirubicin—pancreatic cancer	0.000343	0.000359	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000342	0.000358	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000342	0.000358	CcSEcCtD
Sibutramine—Haemorrhage—Epirubicin—pancreatic cancer	0.000342	0.000358	CcSEcCtD
Sibutramine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000341	0.000357	CcSEcCtD
Sibutramine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00034	0.000356	CcSEcCtD
Sibutramine—Pharyngitis—Epirubicin—pancreatic cancer	0.000339	0.000355	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—pancreatic cancer	0.000338	0.000353	CcSEcCtD
Sibutramine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000337	0.000352	CcSEcCtD
Sibutramine—Hypotension—Docetaxel—pancreatic cancer	0.000336	0.000352	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—pancreatic cancer	0.000336	0.000351	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—pancreatic cancer	0.000332	0.000348	CcSEcCtD
Sibutramine—Vomiting—Irinotecan—pancreatic cancer	0.000331	0.000346	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—pancreatic cancer	0.00033	0.000346	CcSEcCtD
Sibutramine—Dizziness—Fluorouracil—pancreatic cancer	0.00033	0.000345	CcSEcCtD
Sibutramine—Visual impairment—Epirubicin—pancreatic cancer	0.000329	0.000345	CcSEcCtD
Sibutramine—Rash—Irinotecan—pancreatic cancer	0.000328	0.000344	CcSEcCtD
Sibutramine—Dermatitis—Irinotecan—pancreatic cancer	0.000328	0.000343	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000328	0.000343	CcSEcCtD
Sibutramine—Headache—Irinotecan—pancreatic cancer	0.000326	0.000341	CcSEcCtD
Sibutramine—Insomnia—Docetaxel—pancreatic cancer	0.000326	0.000341	CcSEcCtD
Sibutramine—Paraesthesia—Docetaxel—pancreatic cancer	0.000323	0.000338	CcSEcCtD
Sibutramine—Vomiting—Gemcitabine—pancreatic cancer	0.000323	0.000337	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—pancreatic cancer	0.000322	0.000337	CcSEcCtD
Sibutramine—Dyspnoea—Docetaxel—pancreatic cancer	0.000321	0.000336	CcSEcCtD
Sibutramine—Somnolence—Docetaxel—pancreatic cancer	0.00032	0.000335	CcSEcCtD
Sibutramine—Rash—Gemcitabine—pancreatic cancer	0.00032	0.000335	CcSEcCtD
Sibutramine—Dermatitis—Gemcitabine—pancreatic cancer	0.00032	0.000334	CcSEcCtD
Sibutramine—Eye disorder—Epirubicin—pancreatic cancer	0.000319	0.000334	CcSEcCtD
Sibutramine—Tinnitus—Epirubicin—pancreatic cancer	0.000319	0.000333	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000318	0.000333	CcSEcCtD
Sibutramine—Headache—Gemcitabine—pancreatic cancer	0.000318	0.000333	CcSEcCtD
Sibutramine—Vomiting—Fluorouracil—pancreatic cancer	0.000317	0.000332	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—pancreatic cancer	0.000317	0.000332	CcSEcCtD
Sibutramine—Dyspepsia—Docetaxel—pancreatic cancer	0.000317	0.000332	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000316	0.000331	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000315	0.000329	CcSEcCtD
Sibutramine—Rash—Fluorouracil—pancreatic cancer	0.000314	0.000329	CcSEcCtD
Sibutramine—Dermatitis—Fluorouracil—pancreatic cancer	0.000314	0.000329	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000314	0.000328	CcSEcCtD
Sibutramine—Decreased appetite—Docetaxel—pancreatic cancer	0.000313	0.000327	CcSEcCtD
Sibutramine—Headache—Fluorouracil—pancreatic cancer	0.000312	0.000327	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000312	0.000326	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000311	0.000325	CcSEcCtD
Sibutramine—Angiopathy—Epirubicin—pancreatic cancer	0.00031	0.000324	CcSEcCtD
Sibutramine—Nausea—Irinotecan—pancreatic cancer	0.000309	0.000324	CcSEcCtD
Sibutramine—Immune system disorder—Epirubicin—pancreatic cancer	0.000309	0.000323	CcSEcCtD
Sibutramine—Pain—Docetaxel—pancreatic cancer	0.000308	0.000322	CcSEcCtD
Sibutramine—Constipation—Docetaxel—pancreatic cancer	0.000308	0.000322	CcSEcCtD
Sibutramine—Chills—Epirubicin—pancreatic cancer	0.000307	0.000321	CcSEcCtD
Sibutramine—Arrhythmia—Epirubicin—pancreatic cancer	0.000305	0.000319	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—pancreatic cancer	0.000305	0.000319	CcSEcCtD
Sibutramine—Alopecia—Epirubicin—pancreatic cancer	0.000302	0.000316	CcSEcCtD
Sibutramine—Nausea—Gemcitabine—pancreatic cancer	0.000301	0.000315	CcSEcCtD
Sibutramine—Malnutrition—Epirubicin—pancreatic cancer	0.000298	0.000311	CcSEcCtD
Sibutramine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000297	0.00031	CcSEcCtD
Sibutramine—Nausea—Fluorouracil—pancreatic cancer	0.000296	0.00031	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—pancreatic cancer	0.000296	0.000309	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—pancreatic cancer	0.000295	0.000309	CcSEcCtD
Sibutramine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000294	0.000308	CcSEcCtD
Sibutramine—Flatulence—Epirubicin—pancreatic cancer	0.000293	0.000307	CcSEcCtD
Sibutramine—Tension—Epirubicin—pancreatic cancer	0.000292	0.000305	CcSEcCtD
Sibutramine—Dysgeusia—Epirubicin—pancreatic cancer	0.000291	0.000305	CcSEcCtD
Sibutramine—Nervousness—Epirubicin—pancreatic cancer	0.000289	0.000302	CcSEcCtD
Sibutramine—Back pain—Epirubicin—pancreatic cancer	0.000288	0.000301	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—pancreatic cancer	0.000287	0.0003	CcSEcCtD
Sibutramine—Muscle spasms—Epirubicin—pancreatic cancer	0.000286	0.000299	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000286	0.000299	CcSEcCtD
Sibutramine—Body temperature increased—Docetaxel—pancreatic cancer	0.000285	0.000298	CcSEcCtD
Sibutramine—Abdominal pain—Docetaxel—pancreatic cancer	0.000285	0.000298	CcSEcCtD
Sibutramine—Chills—Doxorubicin—pancreatic cancer	0.000284	0.000297	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000283	0.000296	CcSEcCtD
Sibutramine—Vision blurred—Epirubicin—pancreatic cancer	0.00028	0.000293	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—pancreatic cancer	0.000279	0.000292	CcSEcCtD
Sibutramine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000276	0.000289	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—pancreatic cancer	0.000275	0.000288	CcSEcCtD
Sibutramine—Anaemia—Epirubicin—pancreatic cancer	0.000275	0.000288	CcSEcCtD
Sibutramine—Agitation—Epirubicin—pancreatic cancer	0.000273	0.000286	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—pancreatic cancer	0.000271	0.000284	CcSEcCtD
Sibutramine—Tension—Doxorubicin—pancreatic cancer	0.00027	0.000283	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—pancreatic cancer	0.00027	0.000282	CcSEcCtD
Sibutramine—Malaise—Epirubicin—pancreatic cancer	0.000268	0.000281	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—pancreatic cancer	0.000267	0.00028	CcSEcCtD
Sibutramine—Vertigo—Epirubicin—pancreatic cancer	0.000267	0.00028	CcSEcCtD
Sibutramine—Syncope—Epirubicin—pancreatic cancer	0.000267	0.000279	CcSEcCtD
Sibutramine—Leukopenia—Epirubicin—pancreatic cancer	0.000266	0.000279	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—pancreatic cancer	0.000266	0.000279	CcSEcCtD
Sibutramine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000265	0.000278	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000265	0.000277	CcSEcCtD
Sibutramine—Palpitations—Epirubicin—pancreatic cancer	0.000263	0.000275	CcSEcCtD
Sibutramine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000261	0.000274	CcSEcCtD
Sibutramine—Cough—Epirubicin—pancreatic cancer	0.00026	0.000272	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—pancreatic cancer	0.000259	0.000271	CcSEcCtD
Sibutramine—Asthenia—Docetaxel—pancreatic cancer	0.000258	0.00027	CcSEcCtD
Sibutramine—Convulsion—Epirubicin—pancreatic cancer	0.000258	0.00027	CcSEcCtD
Sibutramine—Hypertension—Epirubicin—pancreatic cancer	0.000257	0.000269	CcSEcCtD
Sibutramine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000255	0.000267	CcSEcCtD
Sibutramine—Pruritus—Docetaxel—pancreatic cancer	0.000255	0.000266	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—pancreatic cancer	0.000254	0.000266	CcSEcCtD
Sibutramine—Arthralgia—Epirubicin—pancreatic cancer	0.000253	0.000265	CcSEcCtD
Sibutramine—Myalgia—Epirubicin—pancreatic cancer	0.000253	0.000265	CcSEcCtD
Sibutramine—Chest pain—Epirubicin—pancreatic cancer	0.000253	0.000265	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—pancreatic cancer	0.000253	0.000265	CcSEcCtD
Sibutramine—Anxiety—Epirubicin—pancreatic cancer	0.000252	0.000264	CcSEcCtD
Sibutramine—Discomfort—Epirubicin—pancreatic cancer	0.00025	0.000262	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—pancreatic cancer	0.000248	0.00026	CcSEcCtD
Sibutramine—Dry mouth—Epirubicin—pancreatic cancer	0.000248	0.000259	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—pancreatic cancer	0.000247	0.000259	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—pancreatic cancer	0.000247	0.000258	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—pancreatic cancer	0.000246	0.000258	CcSEcCtD
Sibutramine—Diarrhoea—Docetaxel—pancreatic cancer	0.000246	0.000258	CcSEcCtD
Sibutramine—Confusional state—Epirubicin—pancreatic cancer	0.000245	0.000256	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—pancreatic cancer	0.000243	0.000255	CcSEcCtD
Sibutramine—Oedema—Epirubicin—pancreatic cancer	0.000243	0.000254	CcSEcCtD
Sibutramine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000243	0.000254	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000242	0.000253	CcSEcCtD
Sibutramine—Infection—Epirubicin—pancreatic cancer	0.000241	0.000252	CcSEcCtD
Sibutramine—Cough—Doxorubicin—pancreatic cancer	0.00024	0.000251	CcSEcCtD
Sibutramine—Shock—Epirubicin—pancreatic cancer	0.000239	0.00025	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—pancreatic cancer	0.000239	0.00025	CcSEcCtD
Sibutramine—Dizziness—Docetaxel—pancreatic cancer	0.000238	0.000249	CcSEcCtD
Sibutramine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000238	0.000249	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—pancreatic cancer	0.000238	0.000249	CcSEcCtD
Sibutramine—Tachycardia—Epirubicin—pancreatic cancer	0.000237	0.000248	CcSEcCtD
Sibutramine—Skin disorder—Epirubicin—pancreatic cancer	0.000236	0.000247	CcSEcCtD
Sibutramine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000235	0.000246	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—pancreatic cancer	0.000234	0.000245	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—pancreatic cancer	0.000234	0.000245	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—pancreatic cancer	0.000234	0.000245	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—pancreatic cancer	0.000234	0.000244	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—pancreatic cancer	0.000232	0.000242	CcSEcCtD
Sibutramine—Anorexia—Epirubicin—pancreatic cancer	0.000231	0.000242	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—pancreatic cancer	0.000229	0.00024	CcSEcCtD
Sibutramine—Vomiting—Docetaxel—pancreatic cancer	0.000229	0.000239	CcSEcCtD
Sibutramine—Rash—Docetaxel—pancreatic cancer	0.000227	0.000237	CcSEcCtD
Sibutramine—Hypotension—Epirubicin—pancreatic cancer	0.000227	0.000237	CcSEcCtD
Sibutramine—Dermatitis—Docetaxel—pancreatic cancer	0.000227	0.000237	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—pancreatic cancer	0.000227	0.000237	CcSEcCtD
Sibutramine—Headache—Docetaxel—pancreatic cancer	0.000226	0.000236	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000225	0.000235	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—pancreatic cancer	0.000225	0.000235	CcSEcCtD
Sibutramine—Infection—Doxorubicin—pancreatic cancer	0.000223	0.000234	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000221	0.000231	CcSEcCtD
Sibutramine—Shock—Doxorubicin—pancreatic cancer	0.000221	0.000231	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00022	0.00023	CcSEcCtD
Sibutramine—Insomnia—Epirubicin—pancreatic cancer	0.00022	0.00023	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—pancreatic cancer	0.000219	0.000229	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—pancreatic cancer	0.000218	0.000228	CcSEcCtD
Sibutramine—Paraesthesia—Epirubicin—pancreatic cancer	0.000218	0.000228	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000217	0.000227	CcSEcCtD
Sibutramine—Dyspnoea—Epirubicin—pancreatic cancer	0.000216	0.000227	CcSEcCtD
Sibutramine—Somnolence—Epirubicin—pancreatic cancer	0.000216	0.000226	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—pancreatic cancer	0.000214	0.000224	CcSEcCtD
Sibutramine—Nausea—Docetaxel—pancreatic cancer	0.000214	0.000224	CcSEcCtD
Sibutramine—Dyspepsia—Epirubicin—pancreatic cancer	0.000214	0.000224	CcSEcCtD
Sibutramine—Decreased appetite—Epirubicin—pancreatic cancer	0.000211	0.000221	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—pancreatic cancer	0.00021	0.00022	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00021	0.000219	CcSEcCtD
Sibutramine—Pain—Epirubicin—pancreatic cancer	0.000208	0.000217	CcSEcCtD
Sibutramine—Constipation—Epirubicin—pancreatic cancer	0.000208	0.000217	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000205	0.000214	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—pancreatic cancer	0.000203	0.000213	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000202	0.000211	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—pancreatic cancer	0.0002	0.00021	CcSEcCtD
Sibutramine—Feeling abnormal—Epirubicin—pancreatic cancer	0.0002	0.000209	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—pancreatic cancer	0.0002	0.000209	CcSEcCtD
Sibutramine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000199	0.000208	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000198	0.000207	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000195	0.000204	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000194	0.000203	CcSEcCtD
Sibutramine—Urticaria—Epirubicin—pancreatic cancer	0.000193	0.000202	CcSEcCtD
Sibutramine—Pain—Doxorubicin—pancreatic cancer	0.000192	0.000201	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—pancreatic cancer	0.000192	0.000201	CcSEcCtD
Sibutramine—Abdominal pain—Epirubicin—pancreatic cancer	0.000192	0.000201	CcSEcCtD
Sibutramine—Body temperature increased—Epirubicin—pancreatic cancer	0.000192	0.000201	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000185	0.000194	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000184	0.000192	CcSEcCtD
Sibutramine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000179	0.000187	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—pancreatic cancer	0.000178	0.000187	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000178	0.000186	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000178	0.000186	CcSEcCtD
Sibutramine—Asthenia—Epirubicin—pancreatic cancer	0.000174	0.000182	CcSEcCtD
Sibutramine—Pruritus—Epirubicin—pancreatic cancer	0.000172	0.00018	CcSEcCtD
Sibutramine—Diarrhoea—Epirubicin—pancreatic cancer	0.000166	0.000174	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000166	0.000173	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—pancreatic cancer	0.000161	0.000169	CcSEcCtD
Sibutramine—Dizziness—Epirubicin—pancreatic cancer	0.000161	0.000168	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—pancreatic cancer	0.000159	0.000166	CcSEcCtD
Sibutramine—Vomiting—Epirubicin—pancreatic cancer	0.000154	0.000162	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000154	0.000161	CcSEcCtD
Sibutramine—Rash—Epirubicin—pancreatic cancer	0.000153	0.00016	CcSEcCtD
Sibutramine—Dermatitis—Epirubicin—pancreatic cancer	0.000153	0.00016	CcSEcCtD
Sibutramine—Headache—Epirubicin—pancreatic cancer	0.000152	0.000159	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—pancreatic cancer	0.000149	0.000155	CcSEcCtD
Sibutramine—Nausea—Epirubicin—pancreatic cancer	0.000144	0.000151	CcSEcCtD
Sibutramine—Vomiting—Doxorubicin—pancreatic cancer	0.000143	0.000149	CcSEcCtD
Sibutramine—Rash—Doxorubicin—pancreatic cancer	0.000142	0.000148	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—pancreatic cancer	0.000142	0.000148	CcSEcCtD
Sibutramine—Headache—Doxorubicin—pancreatic cancer	0.000141	0.000147	CcSEcCtD
Sibutramine—Nausea—Doxorubicin—pancreatic cancer	0.000133	0.00014	CcSEcCtD
